Physician profile
David Paul Krewson
NPI 1134124811
$2,334.82
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $168 · 2021: $382 · 2022: $661 · 2023: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $784.87 | 2019-2023 | |
| Pfizer INC. | $169.86 | 2019-2023 | |
| Exeltis, USA INC. | $135.43 | 2021-2023 | Slynd |
| Astellas Pharma US INC | $130.81 | 2019-2023 | Veozah |
| Therapeuticsmd, INC. | $116.49 | 2019-2022 | |
| Myovant Sciences INC. | $101.20 | 2021-2022 | |
| Urovant Sciences INC | $92.17 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $84.18 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.42 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $62.65 | 2019-2023 | Gardasil 9 |
| Allergan, INC. | $62.62 | 2019-2020 | |
| Axonics, INC. | $59.88 | 2022-2023 | Axonics |
| Hologic Sales and Service, LLC | $56.81 | 2019-2023 | Affirm Prone Biopsy System, Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $55.01 | 2023 | Endosee |
| Amag Pharmaceuticals, INC. | $53.68 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $40.69 | 2019-2022 | |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Organon LLC | $32.30 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $31.12 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $30.59 | 2021-2022 | |
| Exact Sciences Corporation | $28.99 | 2023 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $27.04 | 2021-2022 | |
| Eisai INC. | $22.80 | 2023 | |
| Radius Health, INC. | $13.49 | 2023 | Tymlos |
| Myriad Women'S Health, INC. | $13.31 | 2023 | Myrisk |
| Sage Therapeutics, LLC | $12.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Krewson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.